Capricor Therapeutics (CAPR) PT Raised to $10 at Maxim Group, After COVID-19 Drug Study Results
Tweet Send to a Friend
Maxim Group analyst Jason McCarthy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
